SAM
CERE

Silphium Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-123,314
Closed -$5.04M 57
2024
Q2
$5.04M Buy
+123,314
New +$5.04M 2.4% 10